A Study Investigating the Pharmacokinetics (PK) of a single dose administration of Cotadutide (MEDI0382)

Trial Identifier: D5670C00025
Sponsor: MedImmune, LLC
NCTID:: NCT04091373
Start Date: September 2019
Primary Completion Date: March 2020
Study Completion Date: March 2020
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United States of America, FL Daytona Beach, FL, United States of America, 32117